SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : A Good Cancer research Bio company?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Doug Baer who wrote (51)10/17/1996 5:13:00 PM
From: Gary Mohilner   of 76
 
Immunogen which has several drugs that target the cancerous cell may be about to turn the corner on what has generally been a downward path. Funding for the next few years should be established and they may petition for accelerated approval of there Aids Lymphoma drus. The same drug is in Phase 3 trials for lymphoma. I've been an investor in the stock for some time and think they are getting close to a real breakout to the upside. They are also starting to humanize their colon cancer drug that was reported as being very successful in experiments on mice.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News